# Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects

> **NCT00091741** · PHASE1 · COMPLETED · sponsor: **Georgetown University** · enrollment: 10 (estimated)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Etanercept (Enbrel)

## Key facts

- **NCT ID:** NCT00091741
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2009-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00091741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00091741, "Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00091741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*